These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9525905)

  • 1. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression.
    Bauer MK; Vogt M; Los M; Siegel J; Wesselborg S; Schulze-Osthoff K
    J Biol Chem; 1998 Apr; 273(14):8048-55. PubMed ID: 9525905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.
    Li-Weber M; Laur O; Dern K; Krammer PH
    Eur J Immunol; 2000 Feb; 30(2):661-70. PubMed ID: 10671224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation.
    Li-Weber M; Laur O; Hekele A; Coy J; Walczak H; Krammer PH
    Eur J Immunol; 1998 Aug; 28(8):2373-83. PubMed ID: 9710215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NF-κB induces a switch from CD95L-dependent to CD95L-independent and JNK-mediated apoptosis in T cells.
    Kiessling MK; Linke B; Brechmann M; Süss D; Krammer PH; Gülow K
    FEBS Lett; 2010 Nov; 584(22):4679-88. PubMed ID: 20974135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment.
    Chan H; Bartos DP; Owen-Schaub LB
    Mol Cell Biol; 1999 Mar; 19(3):2098-108. PubMed ID: 10022897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes.
    Dudley E; Hornung F; Zheng L; Scherer D; Ballard D; Lenardo M
    Eur J Immunol; 1999 Mar; 29(3):878-86. PubMed ID: 10092091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulation of CD95 (Fas) ligand expression in primary T cells: induction of promoter activation in CD95LP-Luc transgenic mice.
    Norian LA; Latinis KM; Eliason SL; Lyson K; Yang C; Ratliff T; Koretzky GA
    J Immunol; 2000 May; 164(9):4471-80. PubMed ID: 10779747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD95 ligand expression as a mechanism of immune escape in breast cancer.
    Müschen M; Moers C; Warskulat U; Even J; Niederacher D; Beckmann MW
    Immunology; 2000 Jan; 99(1):69-77. PubMed ID: 10651943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system.
    Li-Weber M; Krammer PH
    Semin Immunol; 2003 Jun; 15(3):145-57. PubMed ID: 14563113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?
    Strand S; Hofmann WJ; Hug H; Müller M; Otto G; Strand D; Mariani SM; Stremmel W; Krammer PH; Galle PR
    Nat Med; 1996 Dec; 2(12):1361-6. PubMed ID: 8946836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampicin inhibits CD95-mediated apoptosis of Jurkat T cells via glucocorticoid receptors by modifying the expression of molecules regulating apoptosis.
    Yerramasetti R; Gollapudi S; Gupta S
    J Clin Immunol; 2002 Jan; 22(1):37-47. PubMed ID: 11958592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation.
    Li-Weber M; Laur O; Krammer PH
    Eur J Immunol; 1999 Sep; 29(9):3017-27. PubMed ID: 10508276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M; Weller M
    Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of the expression of CD95 ligand, receptor activator of nuclear factor-kappa B ligand (RANKL), TNF-related apoptosis-inducing ligand (TRAIL), and TNF-alpha during T cell activation.
    Wang R; Zhang L; Zhang X; Moreno J; Luo X; Tondravi M; Shi Y
    J Immunol; 2001 Feb; 166(3):1983-90. PubMed ID: 11160247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter.
    Kirchhoff S; Sebens T; Baumann S; Krueger A; Zawatzky R; Li-Weber M; Meinl E; Neipel F; Fleckenstein B; Krammer PH
    J Immunol; 2002 Feb; 168(3):1226-34. PubMed ID: 11801659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of CD95 activation by caspase 8-induced endosomal acidification in rat hepatocytes.
    Reinehr R; Sommerfeld A; Keitel V; Grether-Beck S; Haüssinger D
    J Biol Chem; 2008 Jan; 283(4):2211-22. PubMed ID: 18045865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas/APO-1 (CD95)-mediated cytotoxicity is responsible for the apoptotic cell death of leukaemic cells induced by interleukin-2-activated T cells.
    Komada Y; Zhou YW; Zhang XL; Chen TX; Tanaka S; Azuma E; Sakurai M
    Br J Haematol; 1997 Jan; 96(1):147-57. PubMed ID: 9012700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels.
    Chang WK; Yang KD; Chuang H; Jan JT; Shaio MF
    Clin Immunol; 2002 Aug; 104(2):151-60. PubMed ID: 12165276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma.
    Bellone G; Smirne C; Carbone A; Mareschi K; Dughera L; Farina EC; Alabiso O; Valente G; Emanuelli G; Rodeck U
    Clin Cancer Res; 2000 Jun; 6(6):2448-55. PubMed ID: 10873098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L.
    Aragane Y; Kulms D; Metze D; Wilkes G; Pöppelmann B; Luger TA; Schwarz T
    J Cell Biol; 1998 Jan; 140(1):171-82. PubMed ID: 9425165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.